Approval · Notice of Compliance 9445 · 2008
RELISTOR: Notice of Compliance 9445
Issued March 28, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9445
- Date
- March 28, 2008
- Company
- Wyeth CanadaSt. Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
- Therapeutic class
- µ-OPIOID RECEPTOR ANTAGONIST
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RELISTOR | 02308215 | Marketed |
Medicinal ingredients
- METHYLNALTREXONE BROMIDE 20 MG per ML